Resveratrol diminishes platelet aggregation and increases susceptibility of K562 tumor cells to natural killer cells

Indian Journal of Biochemistry and Biophysics

Volumn 50, Issue 1, 2013, Pages 14-18

  Toliopoulos, Ioannis K ^a,b   Simos, Yannis V ^a,b   Oikonomidis, Stergios ^a,b   Karkabounas, Spyros C ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Non Profit Foundation   (Greece)

Author keywords

Aggregation; Natural killer cells; Platelets; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; RESVERATROL; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL STRAIN K 562; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; PATHOLOGY; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL COMMUNICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; NEOPLASMS, EXPERIMENTAL; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STILBENES; TREATMENT OUTCOME;

EID: 84874378079     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Evangelou A, Toliopoulos I, Giotis C, Metsios A, Verginadis I, Simos Y, Havelas K, Hadziaivazis G & Karkabounas S (2011) Electromag Biol Med 30, 46-56
2. Kodama N, Komuta K, Sakai N & Nanba H (2002) Biol Pharm Bull 25, 1647-1650
3. Maltseva D V, Sakharov D A, Tonevitsky E A, Northoff H & Tonevitsky A G (2011) Exercise Immunol Rev 17, 150-163
4. Orange J S (2002) Microbes Infect 4, 1545-1558
5. Moretta A (2002) Nature Rev Immunol 2, 957-964
6. Storkus W J & Dawson J R (1991) Crit Rev Immunol 10, 393-416
7. Nieswandt B, Hafner M, Echtenacher B & Mannel D N (1999) Cancer Res 59, 1295-1300
8. Chang S J, Lin J S & Chen H H (2000) Free Radic Biol Med 28, 202-207
9. Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, D'Angelo S, Scilimati A, Sciulli M G & Patrignani P (2006) Circ Res 17, 593-595
10. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S & Thavaramara T (2012) J Gynecol Oncol 23, 265-273
11. Wang Y K, He H L, Wang G F, Wu H, Zhou B C, Chen X L & Zhang Y Z (2010) Marine Drugs 8, 255-268
12. Scalbert A, Johnson I T & Saltmarsh M (2005) Am Clin Nutr 81, 215S-217S
13. Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M & Ravagnan G (2001) Life Sci 70, 81-96
14. Provinciali M, Re F, Donnini A, Orlando F, Bartozzi B, Di Stasio G & Smorlesi A (2005) Int J Cancer 115, 36-45
15. Kimura Y & Okuda H (2001) J Nutr 131, 1844-1849
16. Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans A S & van Ginkel P R (2010) Clin Cancer Res 16, 5942-5948
17. Norseth T (1964) Nordisk Med 71, 375-377
18. Patrono C, Ciabattoni G, Pugliese F, Pinca E, Castrucci G, De Salvo A, Satta A & Parachini M (1980) Adv Prostaglandin Thromboxane Res 6, 187-191
19. Powell W S (1980) Prostaglandins 20, 947-957
20. Hezard N, Metz D, Nazeyrollas P. Nguyen P, Simon G, Daliphard S, Droulle C, Elaerts J & Potron G (1999) Thrombosis Haemostasis 81, 869-873
21. Neri S, Mariani E, Meneghetti A, Cattini L & Facchini A (2001) Clin Diagnostic Lab Immunol 8, 1131-1135
22. Henney C S, Kuribayashi K, Kern D E & Gillis S (1981) Nature 291, 335-338
23. Toliopoulos K I (2007) The role of NKC lymphocytes and substances with antioxidant capacity in cancer, Ph. D. thesis, University of Ioannina, Ioannina
24. Suttnar J, Masova L, Scheiner T, Sorelova V & Dyr J E (2002) Casopís Lékařů Českých 141, 47-49
25. Simmler C, Antheaume C & Lobstein A (2010) PLoS One 5, e137-e138
26. Granados-Soto V (2003) Drug News Perspect 16, 299-307
27. Chakrabarti S, Clutton P, Varghese S, Cox D, Mascelli M A & Freedman J E (2004) Thromb Res 113, 225-233
28. Hundelshausen P & Weber C (2007) Circulat Res 100, 27-40.
29. Parham P (2005) Nature Rev Immunol 5, 201-214
30. Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field J K & Christmas S E (2010) Human Immunol 71, 976-981
31. Lu C C & Chen J K (2010) J Cell Physiol 223, 343-351
32. Bachleda P, Vrzal R and Dvorak Z (2010) J Cellul Physiol 225, 289-290
33. Casper R F, Quesne M, Rogers I M, Shirota T, Jolivet A, Milgrom E & Savouret J F (1999) Mol Pharmacol 56, 784-790
34. Nebert D W, Roe A L, Dieter M Z, Solis W A, Yang Y & Dalton T P (2000) Biochem Pharmacol 59, 65-85
35. Li Q, Kobayashi M, Wakayama Y, Inagaki H, Katsumata M, Hirata Y, Hirata K, Shimizu T, Kawada T, Park BJ, Ohira T, Kagawa T & Miyazaki Y (2009) Int J Immunopathol Pharmacol 22, 951-959